(Q36800487)

16 August 2017

Methylphenidate side effects in advanced cancer: a retrospective analysis (English)

1 reference

16 August 2017

Wael Lasheen

1

1 reference

16 August 2017

Declan Walsh

2

1 reference

16 August 2017

Fade Mahmoud

3

1 reference

16 August 2017

Mellar P Davis

4

1 reference

16 August 2017

Nilo Rivera

5

1 reference

16 August 2017

Dilara Seyidova Khoshknabi

6

1 reference

16 August 2017

10 September 2009

1 reference

American Journal of Hospice and Palliative Medicine

16 August 2017

1 reference

16 August 2017

27

1 reference

16 August 2017

1

1 reference

16 August 2017

16-23

1 reference

Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

Mechanism of action of methylphenidate: insights from PET imaging studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

Palliative uses of methylphenidate in patients with cancer: a review.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

Psychostimulants in supportive care

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

Methylphenidate: its pharmacology and uses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

Symptom control in advanced cancer: important drugs and routes of administration.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

Methylphenidate therapy improves cognition, mood, and function of brain tumor patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

A phase II study of methylphenidate for the treatment of fatigue

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

Methylphenidate in a patient with depression and respiratory insufficiency

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

A phase II study of methylphenidate for depression in advanced cancer

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638151

Methylphenidate associated with narcotics for the treatment of cancer pain

5 September 2018

1 reference

12 December 2020

Methylphenidate for depressive disorders in cancer patients. An alternative to standard antidepressants

1 reference

12 December 2020

The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report

1 reference

12 December 2020

Does haloperidol block methylphenidate? Motivation or attention?

1 reference

12 December 2020

Methylphenidate in terminal depression

1 reference

12 December 2020

Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Methylphenidate for depression in hospice practice: a case series

1 reference

12 December 2020

Identifiers

DOI

10.1177/1049909109345145

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

19745210

1 reference